Analyst Price Targets — EHAB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 1:12 am | — | UBS | $13.80 | $13.60 | TheFly | Enhabit downgraded to Neutral from Buy at UBS |
| February 23, 2026 6:26 pm | — | Jefferies | $13.80 | $13.60 | TheFly | Enhabit downgraded to Hold from Buy at Jefferies |
| February 23, 2026 3:25 pm | — | Leerink Partners | $13.80 | $13.60 | TheFly | Enhabit price target raised to $13.80 from $9.50 at Leerink |
| February 23, 2026 3:22 pm | — | Truist Financial | $13.80 | $13.60 | TheFly | Enhabit price target raised to $13.80 from $10.50 at Truist |
| January 22, 2026 11:47 am | Michael Wiederhorn | Oppenheimer | $14.00 | $10.74 | TheFly | Enhabit upgraded to Outperform from Perform at Oppenheimer |
| January 8, 2026 8:03 am | — | Wolfe Research | $12.00 | $9.51 | StreetInsider | UBS Upgrades Enhabit Home Health & Hospice (EHAB) to Buy |
| January 7, 2026 12:05 pm | — | Truist Financial | $10.50 | $9.44 | TheFly | Enhabit initiated with a Hold at Truist |
| December 16, 2025 1:39 pm | — | Jefferies | $12.00 | $9.73 | TheFly | Enhabit price target raised to $12 from $11 at Jefferies |
| December 9, 2024 9:41 am | Brian Tanquilut | Jefferies | $9.50 | $7.73 | StreetInsider | Jefferies Upgrades Enhabit Home Health & Hospice (EHAB) to Buy |
| May 14, 2024 6:14 am | Whit Mayo | Leerink Partners | $8.50 | $8.64 | TheFly | Enhabit upgraded to Market Perform from Underperform at Leerink |
Latest News for EHAB
DALLAS--(BUSINESS WIRE)--Enhabit, Inc., a leading home health and hospice provider, today announced that Dale Clift has been appointed president and CEO, following the successful completion of the company's acquisition by Kinderhook Industries. Clift succeeds Barb Jacobsmeyer, former president and CEO of Enhabit, who previously announced her intention to step down upon the appointment of a successor. Clift brings…
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Enhabit, Inc. (NYSE: EHAB - Get Free Report) has been given a consensus recommendation of "Hold" by the nine ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating on the company. The average
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EHAB.
U.S. House Trading
No House trades found for EHAB.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.